HIGHLIGHTS
- who: Hongyue Ding and colleagues from the School of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun, China have published the article: Ginsenoside Rb1 Interfered with Macrophage Activation by Activating PPAR to Inhibit Insulin Resistance in Obesity, in the Journal: Molecules 2023, 28, 3083. of 11/01/2023
- what: To further prove that Rb1 can relieve T2D, the authors focused on this study of Rb1 network pharmacology study and explored its possible mechanism of T2D effect or T2D early prevention. For the the study of the cellular level under the local area of adipose_tissue macrophage . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.